UBS Group’s Sangamo Therapeutics SGMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$676K Buy
1,249,009
+638,043
+104% +$345K ﹤0.01% 4628
2025
Q1
$401K Buy
610,966
+276,805
+83% +$182K ﹤0.01% 4829
2024
Q4
$341K Buy
334,161
+235,991
+240% +$241K ﹤0.01% 4941
2024
Q3
$85K Buy
98,170
+12,956
+15% +$11.2K ﹤0.01% 5279
2024
Q2
$30.5K Sell
85,214
-75,086
-47% -$26.9K ﹤0.01% 5893
2024
Q1
$107K Buy
160,300
+18,111
+13% +$12.1K ﹤0.01% 5042
2023
Q4
$77.2K Sell
142,189
-603,791
-81% -$328K ﹤0.01% 5131
2023
Q3
$448K Buy
745,980
+649,133
+670% +$389K ﹤0.01% 3682
2023
Q2
$126K Sell
96,847
-170,766
-64% -$222K ﹤0.01% 4787
2023
Q1
$471K Sell
267,613
-324,441
-55% -$571K ﹤0.01% 3750
2022
Q4
$1.86M Buy
592,054
+485,785
+457% +$1.53M ﹤0.01% 2618
2022
Q3
$520K Sell
106,269
-91,347
-46% -$447K ﹤0.01% 3335
2022
Q2
$818K Sell
197,616
-262,764
-57% -$1.09M ﹤0.01% 3018
2022
Q1
$2.68M Buy
460,380
+51,968
+13% +$302K ﹤0.01% 2431
2021
Q4
$3.06M Buy
408,412
+118,557
+41% +$889K ﹤0.01% 2526
2021
Q3
$2.61M Buy
289,855
+174,571
+151% +$1.57M ﹤0.01% 2550
2021
Q2
$1.38M Sell
115,284
-230,444
-67% -$2.76M ﹤0.01% 3014
2021
Q1
$4.33M Buy
345,728
+306,841
+789% +$3.84M ﹤0.01% 2096
2020
Q4
$607K Buy
38,887
+26,725
+220% +$417K ﹤0.01% 3545
2020
Q3
$115K Sell
12,162
-137,934
-92% -$1.3M ﹤0.01% 4283
2020
Q2
$1.35M Buy
150,096
+126,304
+531% +$1.13M ﹤0.01% 2595
2020
Q1
$151K Buy
23,792
+6,317
+36% +$40.1K ﹤0.01% 4098
2019
Q4
$147K Sell
17,475
-158,242
-90% -$1.33M ﹤0.01% 4782
2019
Q3
$1.59M Buy
175,717
+76,912
+78% +$696K ﹤0.01% 2818
2019
Q2
$1.06M Buy
98,805
+79,056
+400% +$851K ﹤0.01% 3019
2019
Q1
$188K Sell
19,749
-308,410
-94% -$2.94M ﹤0.01% 3877
2018
Q4
$3.77M Buy
328,159
+214,906
+190% +$2.47M ﹤0.01% 1926
2018
Q3
$1.92M Buy
113,253
+36,690
+48% +$622K ﹤0.01% 2632
2018
Q2
$1.09M Sell
76,563
-132,181
-63% -$1.88M ﹤0.01% 3014
2018
Q1
$3.97M Buy
208,744
+198,017
+1,846% +$3.76M ﹤0.01% 2032
2017
Q4
$176K Sell
10,727
-2,567
-19% -$42.1K ﹤0.01% 4103
2017
Q3
$200K Sell
13,294
-17,264
-56% -$260K ﹤0.01% 4008
2017
Q2
$269K Buy
30,558
+23,708
+346% +$209K ﹤0.01% 3728
2017
Q1
$36K Sell
6,850
-11,531
-63% -$60.6K ﹤0.01% 4843
2016
Q4
$56K Buy
18,381
+337
+2% +$1.03K ﹤0.01% 4824
2016
Q3
$83K Sell
18,044
-16,180
-47% -$74.4K ﹤0.01% 4257
2016
Q2
$198K Buy
34,224
+20,724
+154% +$120K ﹤0.01% 3743
2016
Q1
$81K Sell
13,500
-693
-5% -$4.16K ﹤0.01% 4365
2015
Q4
$129K Buy
14,193
+693
+5% +$6.3K ﹤0.01% 4056
2015
Q3
$76K Sell
13,500
-3,800
-22% -$21.4K ﹤0.01% 4400
2015
Q2
$192K Sell
17,300
-8,517
-33% -$94.5K ﹤0.01% 3901
2015
Q1
$405K Sell
25,817
-1,469
-5% -$23K ﹤0.01% 3359
2014
Q4
$415K Buy
+27,286
New +$415K ﹤0.01% 3311